EE200100596A - Ülipuhas (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri[metüül]bitsüklo[2.2.1 ]heptaan ja selle farmatseutiliselt vastuvõetavad happeliitsoolad ning nimetatud ühendite, samutiravimite, mis sisaldavad üks või enam nimetatud üh - Google Patents

Ülipuhas (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri[metüül]bitsüklo[2.2.1 ]heptaan ja selle farmatseutiliselt vastuvõetavad happeliitsoolad ning nimetatud ühendite, samutiravimite, mis sisaldavad üks või enam nimetatud üh

Info

Publication number
EE200100596A
EE200100596A EEP200100596A EEP200100596A EE200100596A EE 200100596 A EE200100596 A EE 200100596A EE P200100596 A EEP200100596 A EE P200100596A EE P200100596 A EEP200100596 A EE P200100596A EE 200100596 A EE200100596 A EE 200100596A
Authority
EE
Estonia
Prior art keywords
compounds
bicyclo
heptane
dimethylamino
ethoxy
Prior art date
Application number
EEP200100596A
Other languages
English (en)
Inventor
nende kasutamine a
Luk�cs Gyula
Simig Gyula
Mezei Tibor
Budai Zolt�n
Porcs-Makkay M�rta
Krasznai Gy�rgy
Nagy K�lm�n
Vereczkeyn� Don�th Gy�rgyi
Szab Tibor
N�meth Norbert
Szul�gyi J�nos
Original Assignee
Egis Gy�Gyszergy�R Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gy�Gyszergy�R Rt. filed Critical Egis Gy�Gyszergy�R Rt.
Publication of EE200100596A publication Critical patent/EE200100596A/et
Publication of EE04672B1 publication Critical patent/EE04672B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/12—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100596A 1999-05-11 2000-05-10 Ülipuhas (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri[metüül]bitsüklo[2.2.1 ]heptaan ja selle farmatseutiliselt vastuvõetavad happeliitsoolad ning nimetatud ühendite, samutiravimite, mis sisaldavad üks või enam nimetatud üh EE200100596A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9901559A HU227114B1 (en) 1999-05-11 1999-05-11 (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
PCT/HU2000/000044 WO2000068183A2 (en) 1999-05-11 2000-05-10 High purity (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them

Publications (2)

Publication Number Publication Date
EE200100596A true EE200100596A (et) 2003-02-17
EE04672B1 EE04672B1 (et) 2006-08-15

Family

ID=89998272

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200100595A EE04638B1 (et) 1999-05-11 2000-05-10 Meetod (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri-[metüül]bitsüklo[2.2 .1]heptaani ja selle farmatseutiliselt vastuvõetavate happeliitsoolade valmistamiseks
EEP200100596A EE200100596A (et) 1999-05-11 2000-05-10 Ülipuhas (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri[metüül]bitsüklo[2.2.1 ]heptaan ja selle farmatseutiliselt vastuvõetavad happeliitsoolad ning nimetatud ühendite, samutiravimite, mis sisaldavad üks või enam nimetatud üh

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EEP200100595A EE04638B1 (et) 1999-05-11 2000-05-10 Meetod (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri-[metüül]bitsüklo[2.2 .1]heptaani ja selle farmatseutiliselt vastuvõetavate happeliitsoolade valmistamiseks

Country Status (37)

Country Link
US (3) US6242386B1 (et)
EP (4) EP1177166B1 (et)
JP (2) JP4536265B2 (et)
KR (3) KR100685071B1 (et)
CN (2) CN1173928C (et)
AR (2) AR023900A1 (et)
AT (4) ATE237579T1 (et)
AU (2) AU777737B2 (et)
BG (2) BG64673B1 (et)
BR (2) BR0010412A (et)
CA (2) CA2369393C (et)
CO (1) CO5170480A1 (et)
CZ (4) CZ291329B6 (et)
DE (4) DE60038112T8 (et)
DK (4) DK1052243T3 (et)
EA (2) EA002164B1 (et)
EE (2) EE04638B1 (et)
ES (4) ES2194643T3 (et)
FR (2) FR2793490B1 (et)
HR (2) HRP20000290B1 (et)
HU (1) HU227114B1 (et)
IL (4) IL146420A0 (et)
IS (2) IS6152A (et)
LT (2) LT4927B (et)
MX (2) MXPA01011423A (et)
MY (2) MY123523A (et)
NO (2) NO321486B1 (et)
NZ (2) NZ515918A (et)
PL (2) PL202956B1 (et)
PT (4) PT1177167E (et)
SI (4) SI1052245T1 (et)
SK (4) SK6892000A3 (et)
TR (2) TR200200147T2 (et)
TW (2) TWI286541B (et)
UA (2) UA49974C2 (et)
WO (2) WO2000068183A2 (et)
ZA (2) ZA200108958B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6589996B2 (en) 2000-03-17 2003-07-08 Orion Corporation Treatment of disorders relating to the serotonergic system
US20040082665A1 (en) * 2001-01-22 2004-04-29 Outi Maki-Ikola Method for treating stress or tension
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
EA010691B1 (ru) * 2004-03-12 2008-10-30 Эгиш Дьёдьсердьяр Нирт. Комбинация дерамциклана и опиоидов в качестве обезболивающего средства
JP4916680B2 (ja) * 2005-06-30 2012-04-18 株式会社半導体エネルギー研究所 半導体装置の作製方法、剥離方法
US20080258121A1 (en) * 2007-04-23 2008-10-23 Hasan Farooq Fire Retardant Composition
RU2578715C2 (ru) 2009-11-19 2016-03-27 Йиссум Рисерч Дивелопмент Компани Оф Дзе Хебрю Юниверсити Оф Иерусалим, Лтд. Новые арилированные камфены, способы их получения и их применения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU212574B (en) * 1990-09-21 1996-08-29 Egyt Gyogyszervegyeszeti Gyar Process for producing (1r,2s)-(-)-2-phenyl-(2'-dimethyl-amino-etoxy)-1,7,7-trimethyl-bicyclo[2.2.1.]heptane
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
HU226061B1 (en) 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same

Also Published As

Publication number Publication date
LT2001109A (en) 2002-03-25
ES2208328T3 (es) 2004-06-16
EP1052243A2 (en) 2000-11-15
DE60006097T2 (de) 2004-06-17
DK1177167T3 (da) 2004-03-01
US20020040164A1 (en) 2002-04-04
JP4536265B2 (ja) 2010-09-01
KR20020010914A (ko) 2002-02-06
PL340108A1 (en) 2000-11-20
SK285780B6 (sk) 2007-08-02
UA49974C2 (uk) 2002-10-15
CA2369393A1 (en) 2000-11-16
AU777737B2 (en) 2004-10-28
FR2793490A1 (fr) 2000-11-17
NO20015336L (no) 2002-01-08
ZA200108956B (en) 2003-02-17
SK16232001A3 (sk) 2002-04-04
HU9901559D0 (en) 1999-07-28
EP1177167B1 (en) 2003-10-22
SI1177166T1 (sl) 2008-08-31
US6242386B1 (en) 2001-06-05
HRP20000290A2 (en) 2005-02-28
TR200200147T2 (tr) 2002-06-21
ES2203373T3 (es) 2004-04-16
HK1031372A1 (en) 2001-06-15
ZA200108958B (en) 2002-10-30
EE04638B1 (et) 2006-06-15
PL202956B1 (pl) 2009-08-31
PT1177167E (pt) 2004-03-31
DE60002117T2 (de) 2003-12-24
NO321487B1 (no) 2006-05-15
EA200000411A3 (ru) 2001-02-26
IS2570B (is) 2010-01-15
FR2793489B1 (fr) 2004-04-02
CA2373193A1 (en) 2000-11-16
EA200000410A2 (ru) 2000-12-25
DK1052245T3 (da) 2003-08-11
EP1052245A3 (en) 2001-02-28
DE60038112D1 (de) 2008-04-03
TR200200148T2 (tr) 2002-06-21
HK1031220A1 (en) 2001-06-08
HRP20000291B1 (en) 2005-06-30
HRP20000291A2 (en) 2001-06-30
EP1052245A2 (en) 2000-11-15
KR100685071B1 (ko) 2007-02-22
EE04672B1 (et) 2006-08-15
AU776696B2 (en) 2004-09-16
BG64442B1 (en) 2005-02-28
DE60002117D1 (de) 2003-05-22
MY122508A (en) 2006-04-29
KR100581489B1 (ko) 2006-05-22
SK6892000A3 (en) 2000-12-11
AR020860A1 (es) 2002-05-29
CZ290734B6 (cs) 2002-10-16
BR0010412A (pt) 2002-02-13
PT1052243E (pt) 2003-12-31
IL146420A0 (en) 2002-07-25
CN1325465C (zh) 2007-07-11
CZ20001723A3 (cs) 2000-12-13
DE60038112T8 (de) 2009-05-28
MXPA01011423A (es) 2002-06-04
TWI286541B (en) 2007-09-11
EP1052243A3 (en) 2001-02-28
DE60006097D1 (de) 2003-11-27
EA002164B1 (ru) 2001-12-24
IS6153A (is) 2001-11-09
SI1052245T1 (en) 2003-10-31
CO5170480A1 (es) 2002-06-27
NO20015352L (no) 2002-01-08
EA002163B1 (ru) 2001-12-24
HU227114B1 (en) 2010-07-28
IS6152A (is) 2001-11-09
UA61122C2 (uk) 2003-11-17
SK6902000A3 (en) 2000-12-11
JP4031203B2 (ja) 2008-01-09
JP2002544184A (ja) 2002-12-24
US6624201B2 (en) 2003-09-23
WO2000068183A3 (en) 2001-07-26
NO20015352D0 (no) 2001-11-01
SI1052243T1 (en) 2004-02-29
AU4600300A (en) 2000-11-21
CN1353687A (zh) 2002-06-12
EP1177166B1 (en) 2008-02-20
CA2369393C (en) 2010-07-06
LT2001108A (en) 2002-03-25
ATE246170T1 (de) 2003-08-15
EA200000411A2 (ru) 2000-12-25
PT1177166E (pt) 2008-06-02
ATE252544T1 (de) 2003-11-15
NZ515917A (en) 2004-02-27
BG104417A (en) 2001-03-30
WO2000068183A2 (en) 2000-11-16
MXPA01011420A (es) 2002-06-04
HRP20000290B1 (en) 2007-08-31
ATE386714T1 (de) 2008-03-15
ES2194643T3 (es) 2003-12-01
IL146421A0 (en) 2002-07-25
DE60004126D1 (de) 2003-09-04
WO2000068181A3 (en) 2001-06-28
LT4927B (lt) 2002-07-25
EP1177167A2 (en) 2002-02-06
PT1052245E (pt) 2003-09-30
NO20015336D0 (no) 2001-10-31
DE60004126T2 (de) 2004-04-22
ATE237579T1 (de) 2003-05-15
KR20060010874A (ko) 2006-02-02
DK1177166T3 (da) 2008-06-16
CN1173928C (zh) 2004-11-03
CZ20014051A3 (cs) 2002-05-15
DK1052243T3 (da) 2003-11-24
US6335469B1 (en) 2002-01-01
BG104416A (en) 2001-03-30
IL146420A (en) 2007-06-03
DE60038112T2 (de) 2009-02-12
ES2302694T3 (es) 2008-08-01
FR2793489A1 (fr) 2000-11-17
NZ515918A (en) 2004-02-27
BG64673B1 (bg) 2005-11-30
BR0010406A (pt) 2002-02-13
PL340107A1 (en) 2000-11-20
SK285635B6 (sk) 2007-05-03
KR20010112486A (ko) 2001-12-20
FR2793490B1 (fr) 2004-04-23
NO321486B1 (no) 2006-05-15
EP1052245B1 (en) 2003-04-16
EP1177166A2 (en) 2002-02-06
HUP9901559A2 (hu) 2002-01-28
EP1052243B1 (en) 2003-07-30
TW528742B (en) 2003-04-21
AU4773100A (en) 2000-11-21
CZ20014050A3 (cs) 2002-05-15
CZ291329B6 (cs) 2003-02-12
LT4928B (lt) 2002-07-25
EE200100595A (et) 2003-02-17
IL146421A (en) 2008-11-26
MY123523A (en) 2006-05-31
CN1353686A (zh) 2002-06-12
AR023900A1 (es) 2002-09-04
CZ20001722A3 (cs) 2000-12-13
WO2000068181A2 (en) 2000-11-16
JP2002544185A (ja) 2002-12-24
SK16242001A3 (sk) 2002-04-04
EA200000410A3 (ru) 2001-02-26
SI1177167T1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
EE200000535A (et) Triasendatud 1,3,5-triasiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutami
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
EE04962B1 (et) Kinoliini ühend, seda sisaldav farmatseutiline kompositsioon, ühendi kasutamine ravimina ning meetod ühendi ja kompositsiooni valmistamiseks
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
EA200200571A1 (ru) Новая композиция и ее применение
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
CA2360220A1 (en) Oxadiazole compounds and compositions for delivering active agents
CA2285037A1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
HK1044145A1 (zh) N-(2-苯基-4-氨基丁基)-1-萘甲酰胺作為神經激肽-1受體拮抗劑
EE200100595A (et) Meetod (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri-[metüül]bitsüklo[2.2.1]heptaani ja selle farmatseutiliselt vastuvõetavate happeliitsoolade valmistamiseks
ATE334655T1 (de) Amoxicillin und clavulanat enthaltende pharmazeutische formulierung
SE9902935D0 (sv) Pharmaceutical compositions
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
CA2192822A1 (en) Use of immunosuppressive agents for the treatment of schizophrenia
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
WO1994016705A3 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
ES2124844T3 (es) Palau'amina: un compuesto farmacologicamente activo aislado a partir de una esponja.
WO2001091733A3 (de) Wirkstoffkombination enthaltend montirelin und eine verbindung mit opioider wirksamkeit
HU9802896D0 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
SE9902596D0 (sv) Pharmaceutically active compounds

Legal Events

Date Code Title Description
HB1A Correction of owner name or address
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110510